Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

634 trials with published results (16%)

Research Maturity

3108 completed trials (80% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

168 terminated out of 3869 trials

Success Rate

94.9%

+8.4% vs benchmark

Late-Stage Pipeline

20%

762 trials in Phase 3/4

Results Transparency

20%

634 of 3108 completed with results

Key Signals

634 with results95% success168 terminated

Data Visualizations

Phase Distribution

3,242Total
Not Applicable (968)
Early P 1 (9)
P 1 (862)
P 2 (641)
P 3 (445)
P 4 (317)

Trial Status

Completed3,108
Unknown266
Terminated168
Recruiting120
Withdrawn94
Active Not Recruiting62

Trial Success Rate

94.9%

Benchmark: 86.5%

Based on 3108 completed trials

Clinical Trials (3869)

Showing 20 of 20 trials
NCT07488221Not ApplicableCompletedPrimary

Male Partner Engagement in HIV Testing Using Partner-notification Slip Plus Oral HIV Self-testing Kit

NCT07629310Phase 1CompletedPrimary

To Evaluate the Safety of JL18008

NCT06109571Not ApplicableActive Not RecruitingPrimary

Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders

NCT03149354Not ApplicableCompleted

Prevalence of Thyroid Function Abnormalities in HIV-infected Patients

NCT05040841Not ApplicableActive Not RecruitingPrimary

Supporting Sustained HIV Treatment Adherence After Initiation

NCT04804072Not ApplicableCompletedPrimary

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

NCT05816083Not ApplicableRecruiting

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

NCT00980538Phase 3CompletedPrimary

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants

NCT07636928Phase 1Not Yet RecruitingPrimary

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

NCT04142047Recruiting

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT06665646Phase 1RecruitingPrimary

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

NCT05165810Not ApplicableCompletedPrimary

Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India

NCT07342491Phase 1RecruitingPrimary

Dasatinib for HIV-1 Reservoir Reduction

NCT06854029Phase 4Not Yet RecruitingPrimary

NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

NCT06853314Not ApplicableRecruitingPrimary

An Effectiveness Trial of the PrEP for WINGS Study

NCT05783297Not ApplicableCompletedPrimary

Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

NCT07624123Not ApplicableNot Yet Recruiting

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV

NCT05343169Not ApplicableActive Not Recruiting

Community-based Education, Navigation, and Support Intervention for Military Veterans

NCT07545746Phase 2Not Yet RecruitingPrimary

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

NCT07473778RecruitingPrimary

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

Scroll to load more

Research Network

Activity Timeline